Stock info Marrone Bio Innovations Inc | Filter  Basic-Info

Marrone Bio Innovations Inc

Marrone Bio Innovations Inc is active in the biotech sector. The past 10 years the (international) industry gained at around 59 percent. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-2016) there is a minus of 59 percent.

The past year was a good year for Marrone Bio Innovations Inc investors

Over the period from December 2015 till December 2016 the stock gained around 86 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 0 percent. Marrone Bio Innovations Inc's revenues between 2011 and 2015 were quite unstable and moved between 7,14 million dollars and 9,8 million dollars. Marrone Bio Innovations Inc's net results between 2011 and 2015 were far from constant and moved between -13,18 million dollars and -43,73 million dollars.

Marrone Bio Innovations Inc didn't pay out any dividends (in the past 5 years).

Healthy financed: not so much debt Marrone Bio Innovations Inc

Last year the balance sheet of the American company was worth 71,77 million dollars. The total debt of the biotech company was at the end of 2015 73,79 million dollars, which equals around 102,81 percent of the total balance sheet. At the end of 2015 the biotech company's stock was traded with a price/earnings-ratio -2. So the stock' value was -2 times the 2015' earnings per share. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the biotech company's market capitalization (the number of shares times the market price) equaled around 26,43 million dollars. At the end of 2015 the American company had around 24,47 million stocks listed on the exchanges.

All the company's financial reports are available here. More information about Marrone Bio Innovations Inc can be found it's website. .